Max Rosett is Chief Financial Officer of Immunome Inc.. Currently has a direct ownership of 47,476 shares of IMNM, which is worth approximately $450,072. The most recent transaction as insider was on Sep 19, 2024, when has been sold 14,380 shares (Common Stock) at a price of $16.01 per share, resulting in proceeds of $230,223. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.5K
n/a 3M change
n/a 12M change
Total Value Held $450,072

Max Rosett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 19 2024
SELL
Open market or private sale
$230,223 $16.01 p/Share
14,380 Reduced 23.25%
47,476 Common Stock
Sep 19 2024
BUY
Exercise of conversion of derivative security
$44,100 $1.05 p/Share
42,000 Added 40.44%
61,856 Common Stock
MR

Max Rosett

Chief Financial Officer
Exton, PA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM